How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/infection-by-larvae-of-trichinella-spiralis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Infection by larvae of Trichinella spiralis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Infection by larvae of Trichinella spiralis (disease) competitive landscape: 9 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

9 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Infection by larvae of Trichinella spiralis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Decadron	dexamethasone	Generic (originally Merck)	Corticosteroid [EPC]	Annexin A1, Interleukin-4, Androgen receptor	1958-10-30
Medrol	methylprednisolone	Generic (originally Upjohn/Pfizer)	Glucocorticoid (corticosteroid)	Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor	1957-10-01
Deltasone	prednisone	Generic (originally Schering)	Corticosteroid [EPC]	Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor	1955-01-01
Solu-Cortef	hydrocortisone succinate	Pfizer	Corticosteroid	Glucocorticoid receptor	1955-01-01
Cortef	hydrocortisone	Generic (originally Merck/Upjohn)	Corticosteroid [EPC]	Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible	1952-01-01
Cortifoam	HYDROCORTISONE ACETATE	Pfizer	Corticosteroid	Corticosteroid-binding globulin	1951-01-01
prednison	prednison	Wen Zhang		Annexin A1, Sodium/nucleoside cotransporter 1, Glucocorticoid receptor
Cortisol	Cortisol	University of Zurich		Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible
Methylprednisolon	Methylprednisolon	Leiden University Medical Center		Annexin A1, Short transient receptor potential channel 5, Glucocorticoid receptor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 4 drugs in Infection by larvae of Trichinella spiralis
Pfizer · 2 drugs in Infection by larvae of Trichinella spiralis
Generic (originally Merck/Upjohn) · 1 drug in Infection by larvae of Trichinella spiralis
Generic (originally Schering) · 1 drug in Infection by larvae of Trichinella spiralis
Generic (originally Upjohn/Pfizer) · 1 drug in Infection by larvae of Trichinella spiralis
Leiden University Medical Center · 1 drug in Infection by larvae of Trichinella spiralis
University of Zurich · 1 drug in Infection by larvae of Trichinella spiralis
Wen Zhang · 1 drug in Infection by larvae of Trichinella spiralis
Generic (originally Merck) · 1 drug in Infection by larvae of Trichinella spiralis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Infection by larvae of Trichinella spiralis:

Cite this brief

Drug Landscape (2026). Infection by larvae of Trichinella spiralis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/infection-by-larvae-of-trichinella-spiralis. Accessed 2026-06-10.

Infection by larvae of Trichinella spiralis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing